Regulations.gov document
Determination That GLUCOPHAGE (Metformin Hydrochloride) Oral Tablets, 500 Milligrams, 850…
Notice · FDA-2019-P-3877 · posted Dec 31, 2019
Key facts
| Document ID | FDA-2019-P-3877-0003 |
|---|---|
| Title | Determination That GLUCOPHAGE (Metformin Hydrochloride) Oral Tablets, 500 Milligrams, 850 Milligrams, and 1 Gram, and GLUCOPHAGE XR (Metformin Hydrochloride) Oral Extended-Release Tablets, 500 Milligrams and 750 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2019-P-3877 |
| Posted | Dec 31, 2019 |
| Federal Register citation | 84 FR 72366 |
| FR document number | 2019-28270 |
| Comment period opens | Dec 31, 2019 |
| Effective date | Dec 31, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: